Literature DB >> 21174170

Post-stroke infection: a role for IL-1ra?

Pat Tanzi1, Kevin Cain, Angela Kalil, Dannielle Zierath, Anna Savos, J Michael Gee, Dean Shibata, Jessica Hadwin, Kelly Carter, Kyra Becker.   

Abstract

BACKGROUND: Infection is common following stroke and is independently associated with worse outcome. Clinical studies suggest that infections occur more frequently in those individuals with stroke-induced immunologic dysfunction. This study sought to explore the contribution of immunomodulatory cytokines and hormones to lymphocyte function and infection risk.
METHODS: Patients (N = 112) were enrolled as soon as possible after the onset of ischemic stroke. Blood was drawn to assess plasma cortisol, IL-10, IL-1ra, lymphocyte numbers, and lymphocyte function at 72 h after stroke onset; infections were censored through 21 days after stroke onset.
RESULTS: Infection occurred in 25% of patients. Stroke severity was the most important predictor of infection risk. Increased plasma cortisol, IL-10, and IL-1ra, as well as decreased lymphocyte numbers, at 72 h after stroke onset were associated with risk of subsequent infection. After controlling for stroke severity, only IL-1ra was independently associated with infection risk, and the degree of risk was consistent throughout the post-stroke period. Infection, but not IL-1ra itself, was associated with worse outcome at 3 months.
CONCLUSIONS: In this study cohort, increased plasma IL-1ra was independently associated with the risk of post-stroke infection. Further studies are needed to validate this finding, which could have important implications for stroke therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21174170      PMCID: PMC4096896          DOI: 10.1007/s12028-010-9490-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  24 in total

Review 1.  Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke.

Authors:  Victoria Banwell; Emily S Sena; Malcolm R Macleod
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Jul-Aug       Impact factor: 2.136

Review 2.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection.

Authors:  Andreas Hug; Alexander Dalpke; Nina Wieczorek; Thomas Giese; Alexander Lorenz; Gerd Auffarth; Arthur Liesz; Roland Veltkamp
Journal:  Stroke       Date:  2009-08-06       Impact factor: 7.914

4.  Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey.

Authors:  Frederique H Vermeij; Wilma J M Scholte op Reimer; Peter de Man; Robert J van Oostenbrugge; Cees L Franke; Gosse de Jong; Paul L M de Kort; Diederik W J Dippel
Journal:  Cerebrovasc Dis       Date:  2009-03-28       Impact factor: 2.762

5.  Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial.

Authors:  S Aslanyan; C J Weir; H-C Diener; M Kaste; K R Lees
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

6.  Monocytes are major players in the prognosis and risk of infection after acute stroke.

Authors:  Xabier Urra; Alvaro Cervera; Víctor Obach; Núria Climent; Anna M Planas; Angel Chamorro
Journal:  Stroke       Date:  2009-01-22       Impact factor: 7.914

7.  Functional status of peripheral blood T-cells in ischemic stroke patients.

Authors:  Antje Vogelgesang; Verena E L May; Uwe Grunwald; Maren Bakkeboe; Soenke Langner; Henry Wallaschofski; Christof Kessler; Barbara M Bröker; Alexander Dressel
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

8.  A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.

Authors:  H C A Emsley; C J Smith; R F Georgiou; A Vail; S J Hopkins; N J Rothwell; P J Tyrrell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

9.  Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Authors:  Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

Review 10.  Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Authors:  C Salliot; M Dougados; L Gossec
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103

View more
  22 in total

1.  Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke.

Authors:  Candice M Brown; Cheryl D Bushnell; Gregory P Samsa; Larry B Goldstein; Carol A Colton
Journal:  Transl Stroke Res       Date:  2015-09-15       Impact factor: 6.829

2.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

3.  Myelin basic protein autoantibodies, white matter disease and stroke outcome.

Authors:  Dean Shibata; Kevin Cain; Patricia Tanzi; Dannielle Zierath; Kyra Becker
Journal:  J Neuroimmunol       Date:  2012-08-29       Impact factor: 3.478

4.  Functional polymorphisms in toll-like receptor 4 are associated with worse outcome in acute ischemic stroke patients.

Authors:  Jonathan R Weinstein; Juliane Schulze; Richard V Lee; Hunter Phillips; Dannielle Zierath; Patricia Tanzi; Dean Shibata; Kevin C Cain; Kyra J Becker
Journal:  Neuroreport       Date:  2014-05-28       Impact factor: 1.837

5.  Activation of immune responses to brain antigens after stroke.

Authors:  Kyra J Becker
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

6.  The contribution of antibiotics, pneumonia and the immune response to stroke outcome.

Authors:  Kyra J Becker; Dannielle Zierath; Allison Kunze; Leia Fecteau; Brian Lee; Shawn Skerrett
Journal:  J Neuroimmunol       Date:  2016-04-16       Impact factor: 3.478

7.  Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke.

Authors:  Dannielle Zierath; Pat Tanzi; Kevin Cain; Dean Shibata; Kyra Becker
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

8.  Stroke, IL-1ra, IL1RN, infection and outcome.

Authors:  Kyra J Becker; Dorender Dankwa; Richard Lee; Juliane Schulze; Dannielle Zierath; Patricia Tanzi; Kevin Cain; Alexander Dressel; Dean Shibata; Jonathan Weinstein
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

9.  Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries.

Authors:  Sylvie Girard; Hugues Sébire; Marie-Elsa Brochu; Sinziana Briota; Philippe Sarret; Guillaume Sébire
Journal:  Brain Behav Immun       Date:  2012-09-13       Impact factor: 7.217

Review 10.  The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development.

Authors:  Kristy A Zera; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.